SubHero Banner
Text

September 2020

Core topics in this month’s edition include:

  • Gavreto (pralsetinib) - new orphan drug approval
  • Bethkis (tobramcyin) - first time generic
  • Tykerb (lapatinib) - first time generic

Download PDF

Text